Heyue Du

428 total citations
17 papers, 265 citations indexed

About

Heyue Du is a scholar working on Surgery, Economics and Econometrics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Heyue Du has authored 17 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Economics and Econometrics and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Heyue Du's work include Lipoproteins and Cardiovascular Health (5 papers), Pharmaceutical Economics and Policy (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Heyue Du is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Pharmaceutical Economics and Policy (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Heyue Du collaborates with scholars based in China, United States and Norway. Heyue Du's co-authors include Baihai Su, Sheyu Li, Yupei Li, Jiameng Li, Zhenqiang Shi, Na Su, Liya Wang, Xin Song, Weifeng Zhao and Haoming Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Carbohydrate Polymers and Heart.

In The Last Decade

Heyue Du

16 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heyue Du China 10 75 44 38 32 31 17 265
Yuri Kim South Korea 10 77 1.0× 6 0.1× 18 0.5× 86 2.7× 17 0.5× 39 372
Gaurav Gupta India 13 37 0.5× 8 0.2× 23 0.6× 56 1.8× 24 0.8× 53 399
Paul Herbert United Kingdom 11 166 2.2× 151 3.4× 6 0.2× 121 3.8× 35 1.1× 26 478
Sofia Ish‐Shalom Israel 12 59 0.8× 27 0.6× 7 0.2× 55 1.7× 7 0.2× 20 328
Michał Ćwiertnia Poland 8 55 0.7× 77 1.8× 5 0.1× 79 2.5× 10 0.3× 14 252
Kiron Varghese India 9 159 2.1× 15 0.3× 11 0.3× 28 0.9× 10 0.3× 38 352
Yingyu Liu China 11 24 0.3× 59 1.3× 5 0.1× 34 1.1× 12 0.4× 27 326
Hao Yu Chen Canada 11 120 1.6× 47 1.1× 8 0.2× 33 1.0× 10 0.3× 19 311

Countries citing papers authored by Heyue Du

Since Specialization
Citations

This map shows the geographic impact of Heyue Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heyue Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heyue Du more than expected).

Fields of papers citing papers by Heyue Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heyue Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heyue Du. The network helps show where Heyue Du may publish in the future.

Co-authorship network of co-authors of Heyue Du

This figure shows the co-authorship network connecting the top 25 collaborators of Heyue Du. A scholar is included among the top collaborators of Heyue Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heyue Du. Heyue Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ye, Lin, Hui Wang, Heyue Du, et al.. (2025). The Lung Is Not a Primary Site of Platelet Biogenesis. Physiological Research. 74(2). 263–273.
2.
Shao, Heng, Heyue Du, Quan Gan, et al.. (2023). Trends of the Global Burden of Disease Attributable to Cannabis Use Disorder in 204 Countries and Territories, 1990–2019: Results from the Disease Burden Study 2019. International Journal of Mental Health and Addiction. 22(4). 2485–2507. 27 indexed citations
3.
Gan, Lei, Heyue Du, Qiukui Hao, et al.. (2023). Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults. International Journal of Technology Assessment in Health Care. 39(1). e53–e53. 6 indexed citations
4.
Geng, Jiwen, Yupei Li, Jiameng Li, et al.. (2022). Associations Between 25-Hydroxyvitamin D, Kidney Function, and Insulin Resistance Among Adults in the United States of America. Frontiers in Nutrition. 8. 716878–716878. 10 indexed citations
5.
Du, Heyue, Qingyang Shi, Peige Song, et al.. (2022). Global Burden Attributable to High Low-Density Lipoprotein-Cholesterol From 1990 to 2019. Frontiers in Cardiovascular Medicine. 9. 903126–903126. 25 indexed citations
6.
Li, Jing, Heyue Du, Yang Wang, et al.. (2022). Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis. Heart. 108(16). 1296–1302. 14 indexed citations
7.
Zhou, Yiling, Simona Hapca, Samira Bell, et al.. (2022). Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes. Journal of Clinical Medicine. 11(22). 6692–6692. 6 indexed citations
8.
Wang, Yang, Heyue Du, Jing Li, et al.. (2022). Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies. SHILAP Revista de lepidopterología. 1(1). e000134–e000134. 22 indexed citations
9.
Zheng, Qin, Ruoxi Liao, Luojia Jiang, et al.. (2021). A narrative review of exosomes in vascular calcification. Annals of Translational Medicine. 9(7). 579–579. 19 indexed citations
10.
Jiang, Luojia, Yupei Li, Heyue Du, Qin Zheng, & Baihai Su. (2021). Effect of Anticoagulant Administration on the Mortality of Hospitalized Patients With COVID-19: An Updated Systematic Review and Meta-Analysis. Frontiers in Medicine. 8. 698935–698935. 7 indexed citations
11.
Xu, Fan, et al.. (2021). Adverse events associated with mirabegron 50 mg versus placebo: A systematic review and meta-analysis. Progrès en Urologie. 31(11). 627–633. 6 indexed citations
12.
Li, Yupei, Jiameng Li, Zhenqiang Shi, et al.. (2020). Anticoagulant chitosan-kappa-carrageenan composite hydrogel sorbent for simultaneous endotoxin and bacteria cleansing in septic blood. Carbohydrate Polymers. 243. 116470–116470. 56 indexed citations
13.
Wang, Liya, Jiameng Li, Si Sun, et al.. (2020). Predictors of successful discontinuation from renal replacement therapy during AKI: A meta‐analysis. Seminars in Dialysis. 34(2). 137–146. 6 indexed citations
14.
Du, Heyue, Xiaodan Li, Na Su, et al.. (2019). Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis. Heart. 105(15). 1149–1159. 26 indexed citations
15.
Su, Na, Yun Li, Ting Xu, et al.. (2016). Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials. International Journal of Cardiology. 219. 293–300. 18 indexed citations
16.
Ma, Yilong, et al.. (2009). Anisotropic Nanocomposite $\hbox{Nd}_{2}\hbox{Fe}_{14}\hbox{B}/\alpha$–$\hbox{Fe}$ Magnets Prepared by Spark Plasma Sintering. IEEE Transactions on Magnetics. 45(6). 2605–2607. 16 indexed citations
17.
Ji, Qingqing, et al.. (2002). Allele Frequencies of CODIS STR Loci in Chinese Population. Journal of Forensic Sciences. 47(5). 1–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026